{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:27:36Z","timestamp":1793755656800,"version":"4.6.1"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":258,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P50 CA186781"],"award-info":[{"award-number":["P50 CA186781"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA271410"],"award-info":[{"award-number":["CA271410"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018866","name":"Paula and Rodger Riney Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic Arizona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.lrr.2026.100611","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:01:17Z","timestamp":1789603277000},"page":"100611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["T cell dysfunction associated with repeated CAR-T cell manufacturing failure following prolonged bispecific antibody exposure: a case report"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5132-3948","authenticated-orcid":false,"given":"Skylar J.W.","family":"Henry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8450-780X","authenticated-orcid":false,"given":"Kirsten","family":"Pfeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3448-9452","authenticated-orcid":false,"given":"Kevin G.","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9709-7624","authenticated-orcid":false,"given":"Erin W.","family":"Meermeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia E.","family":"Wiedmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Chhabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1523-7388","authenticated-orcid":false,"given":"P. Leif","family":"Bergsagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5938-3769","authenticated-orcid":false,"given":"Rafael","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex M.","family":"Wonnaparhown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5514-7072","authenticated-orcid":false,"given":"Michael P.","family":"Gustafson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.lrr.2026.100611_bib0001","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1016\/j.ymthe.2025.07.045","article-title":"Advancing CAR-T cell therapy: insights into patient biology, leukapheresis, and cryopreservation","volume":"33","author":"Vega-Blanco","year":"2025","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.lrr.2026.100611_bib0002","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1182\/bloodadvances.2023011992","article-title":"Early predictive factors of failure in autologous CAR T-cell manufacturing and\/or efficacy in hematologic malignancies","volume":"8","author":"Baguet","year":"2024","journal-title":"Blood Adv."},{"issue":"8","key":"10.1016\/j.lrr.2026.100611_bib0003","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/s41409-025-02623-0","article-title":"CAR-T cell manufacturing failures and out-of-specification products in the real-world setting: a survey from the EBMT cellular therapy and immunobiology working party","volume":"60","author":"Worel","year":"2025","journal-title":"Bone Marrow Transpl."},{"issue":"3","key":"10.1016\/j.lrr.2026.100611_bib0004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121546","article-title":"A method for identification and analysis of non-overlapping myeloid immunophenotypes in humans","volume":"10","author":"Gustafson","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.lrr.2026.100611_bib0005","first-page":"107","article-title":"Socioeconomic and race\/ethnic differences in immunosenescence: evidence from the Health and Retirement Study","author":"Noppert","year":"2023","journal-title":"Brain Behav. Immun."},{"issue":"7","key":"10.1016\/j.lrr.2026.100611_bib0006","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1016\/j.ymthe.2025.03.019","article-title":"Immunophenotype of CAR T cells and apheresis products predicts response in CD22 CAR T cell trial for B cell acute lymphoblastic leukemia","volume":"33","author":"Dreyzin","year":"2025","journal-title":"Mol. Ther."},{"issue":"9","key":"10.1016\/j.lrr.2026.100611_bib0007","doi-asserted-by":"crossref","first-page":"e693","DOI":"10.1016\/S2352-3026(24)00186-8","article-title":"Mechanisms of resistance against T-cell engaging bispecific antibodies in multiple myeloma: implications for novel treatment strategies","volume":"11","author":"van de Donk","year":"2024","journal-title":"Lancet Haematol."},{"issue":"2","key":"10.1016\/j.lrr.2026.100611_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2025.01.634","article-title":"Contributing Factors of Manufacturing Failure for BCMA CAR-T Cell Products in Multiple Myeloma","volume":"31","author":"Sparrow","year":"2025","journal-title":"Transplant. Cell. Ther."},{"issue":"1","key":"10.1016\/j.lrr.2026.100611_bib0009","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1158\/2643-3230.BCD-24-0118","article-title":"Bispecific antibodies as bridging to BCMA CAR-T cell therapy for relapsed\/refractory multiple myeloma","volume":"6","author":"Fandrei","year":"2025","journal-title":"Blood Cancer Discov."},{"issue":"17","key":"10.1016\/j.lrr.2026.100611_bib0010","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1182\/blood.2025029773","article-title":"Sequential targeting in multiple myeloma: talquetamab, a GPRC5D bispecific antibody, as a bridge to BCMA CAR-T therapy","volume":"146","author":"Dhakal","year":"2025","journal-title":"Blood."},{"issue":"11","key":"10.1016\/j.lrr.2026.100611_bib0011","doi-asserted-by":"crossref","DOI":"10.1002\/hem3.70260","article-title":"Sequencing BCMA- and GPRC5D-targeting immunotherapies in multiple Myeloma: practical guidance from the European Myeloma network","volume":"9","author":"van de Donk","year":"2025","journal-title":"Hemasphere"}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048926000518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048926000518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:10:26Z","timestamp":1793754626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048926000518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":11,"alternative-id":["S2213048926000518"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2026.100611","relation":{},"ISSN":["2213-0489"],"issn-type":[{"value":"2213-0489","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T cell dysfunction associated with repeated CAR-T cell manufacturing failure following prolonged bispecific antibody exposure: a case report","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2026.100611","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100611"}}